Literature DB >> 16322273

Phosphatase protein homologue to tensin expression and phosphatidylinositol-3 phosphate kinase mutations in colorectal cancer.

Milo Frattini, Stefano Signoroni, Silvana Pilotti, Lucio Bertario, Silvia Benvenuti, Carlo Zanon, Alberto Bardelli, Marco A Pierotti.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16322273     DOI： 10.1158/0008-5472.CAN-05-2780

Source DB:  PubMed          Journal:  Cancer Res        ISSN： 0008-5472            Impact factor:   12.701


× No keyword cloud information.
  21 in total

1.  Intestinal epithelial-specific PTEN inactivation results in tumor formation.

Authors:  Do-Sun Byun; Naseem Ahmed; Shannon Nasser; Joongho Shin; Sheren Al-Obaidi; Sanjay Goel; Georgia A Corner; Andrew J Wilson; Dustin J Flanagan; David S Williams; Leonard H Augenlicht; Elizabeth Vincan; John M Mariadason
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2011-08-11       Impact factor: 4.052

2.  Association of genetic polymorphisms in PTEN and additional interaction with alcohol consumption and smoking on colorectal cancer in Chinese population.

Authors:  Mingyang Han; Gang Wu; Peichun Sun; Jiewei Nie; Jiancheng Zhang; Yuanyuan Li
Journal:  Int J Clin Exp Med       Date:  2015-11-15

3.  PTEN gene expression and mutations in the PIK3CA gene as predictors of clinical benefit to anti-epidermal growth factor receptor antibody therapy in patients with KRAS wild-type metastatic colorectal cancer.

Authors:  Arjun Sood; Danielle McClain; Radhashree Maitra; Atrayee Basu-Mallick; Raviraja Seetharam; Andreas Kaubisch; Lakshmi Rajdev; John M Mariadason; Kathryn Tanaka; Sanjay Goel
Journal:  Clin Colorectal Cancer       Date:  2012-01-28       Impact factor: 4.481

Review 4.  Microsatellite instability in colorectal cancer-the stable evidence.

Authors:  Eduardo Vilar; Stephen B Gruber
Journal:  Nat Rev Clin Oncol       Date:  2010-02-09       Impact factor: 66.675

5.  Phase II study of everolimus in patients with metastatic colorectal adenocarcinoma previously treated with bevacizumab-, fluoropyrimidine-, oxaliplatin-, and irinotecan-based regimens.

Authors:  Kimmie Ng; Josep Tabernero; Jimmy Hwang; Emilio Bajetta; Sunil Sharma; Salvatore A Del Prete; Edward R Arrowsmith; David P Ryan; Michaela Sedova; Jin Jin; Kamel Malek; Charles S Fuchs
Journal:  Clin Cancer Res       Date:  2013-06-06       Impact factor: 12.531

6.  Mammalian target of rapamycin expression in poorly differentiated endocrine carcinoma: clinical and therapeutic future challenges.

Authors:  Laura Catena; Emilio Bajetta; Massimo Milione; Monika Ducceschi; Monica Valente; Francesca Dominoni; Valentina Colonna
Journal:  Target Oncol       Date:  2011-04-06       Impact factor: 4.493

7.  Multiple roles and therapeutic implications of Akt signaling in cancer.

Authors:  Emiliano Calvo; Victoria Bolós; Enrique Grande
Journal:  Onco Targets Ther       Date:  2009-02-18       Impact factor: 4.147

8.  PIK3CA mutation/PTEN expression status predicts response of colon cancer cells to the epidermal growth factor receptor inhibitor cetuximab.

Authors:  Minaxi Jhawer; Sanjay Goel; Andrew J Wilson; Cristina Montagna; Yi-He Ling; Do-Sun Byun; Shannon Nasser; Diego Arango; Joongho Shin; Lidija Klampfer; Leonard H Augenlicht; Roman Perez-Soler; Roman Perez Soler; John M Mariadason
Journal:  Cancer Res       Date:  2008-03-15       Impact factor: 12.701

9.  Regulation of PTEN expression by the SWI/SNF chromatin-remodelling protein BRG1 in human colorectal carcinoma cells.

Authors:  T Watanabe; S Semba; H Yokozaki
Journal:  Br J Cancer       Date:  2010-11-23       Impact factor: 7.640

10.  Loss of PTEN expression is associated with colorectal cancer liver metastasis and poor patient survival.

Authors:  Hirozumi Sawai; Akira Yasuda; Nobuo Ochi; Jiachi Ma; Yoichi Matsuo; Takehiro Wakasugi; Hiroki Takahashi; Hitoshi Funahashi; Mikinori Sato; Hiromitsu Takeyama
Journal:  BMC Gastroenterol       Date:  2008-11-26       Impact factor: 3.067
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.